DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Krishnan P, Schnell G, Tripathi R. , et al.
Pooled resistance analysis in HCV genotype 1–6-infected patients treated with glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials.
J Hepatol 2017;
66 (Suppl. 01) S500
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.